NCT00090168

Cholesterol Lowering Level of MK0653A+Simvastatin in Patients With Hypercholesterolemia and Atherosclerotic or Coronary Vascular Disease (0653A-806)(COMPLETED)

A Multicenter Study to Assess the Cholesterol Lowering Level of Switching to an Investigational Drug Compared to Doubling the Dose of an Investigational Drug in Patients With Hypercholesterolemia and Atherosclerotic or Coronary Vascular Disease

• Status: Completed
• Phase: Phase 3
• Study type: Interventional
• Enrollment: 435 (actual)
• Sponsor: Organon and Co · Industry
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

A 6-week treatment study to compare the reduction in cholesterol of two drugs MK0653A+Simvastatin for high cholesterol, in patients with hypercholesterolemia and atherosclerotic or coronary vascular disease.

Conditions

• Hypercholesterolemia
• Atherosclerotic Disease
• Coronary Disease

Interventions

Type	Name	Description
DRUG	MK0653A , ezetimibe (+) simvastatin
DRUG	Comparator: atorvastatin
DRUG	Duration of Treatment: 6 weeks

Timeline

• Start date: 2004-01-27
• Primary completion: 2004-10-20
• Completion: 2004-11-10
• First posted: 2004-08-27
• Last updated: 2024-08-15